CURE ACTIVE: No Loss of Clopidogrel Efficacy with the CYP2C19 Loss-of-Function Allele in Patients with ACS or AF

Article Information

DOI 
http://dx.doi.org/10.1177/155989771008025
Published By 
SAGE Publications
Print ISSN 
1559-8977
Online ISSN 
2155-756X
Copyright & Usage 
© 2010 MD Conference Express

Author Information

  1. Anne Jacobson
  1. Guillaume Paré, MD, MSc
    1. McMaster University, Hamilton, Ontario, Canada
View Full Text

Article usage

AbstractFullPDF
Apr 2015500
May 2015100
Jul 2015011
Aug 2015200
Sep 2015100
Oct 2015232
Nov 2015010
Total1153

Note: Article usage statistics are calculated and reported monthly.

Cited By...

  • No citing articles found.
Back to top

Tools

View Full Page PDF
Citation Tools
Email
CURE ACTIVE: No Loss of Clopidogrel Efficacy with the CYP2C19 Loss-of-Function Allele in Patients with ACS or AF
Permalink: Copy
Linkedin Share Button del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo StumbleUpon logo

Table of contents

Cited By...

  • No citing articles found.

Keywords

Myocardial Infarction
Cardiology Genomics
Arrhythmias